MISUSE AND ABUSE OF DRUGS: A CROSS-SECTIONAL SURVEY AMONG PHARMACY PROFESSIONALS IN SAUDI ARABIA
Prescription and non-prescription medication misuse or abuse is a global problem that has a negative impact on all human life aspects, including health, social, economic, and security status. According to the United Nations Office on Drug and Crime reports, over 5% of adult people used drugs at least once in the year 2015, and 29.5 million of them were suffered from the consequences of inappropriate use of drugs. Information on the knowledge and perception among pharmacists regarding the misuse and abuse medications in Saudi Arabia are limited, and therefore, a study was conducted among pharmacy staff to assess their knowledge and awareness on drug misuse and abuse. A cross-sectional study was carried out in Eastern Province, Saudi Arabia. Pharmacy professionals with more than three months of experience were included in the study. A structured questionnaire was used to obtain the participant's responses. A Chi-square test was used to evaluate the association of sociodemographic factors with the participant's responses. Ninety pharmacy professionals were responded. Overall, 69 (76.7%) participants agreed that misuse and abuse are two different terms. In addition, the study showed different responses for patients who suspected to be medication abusers. In conclusion, this study provides an initial picture of pharmacy staffs' knowledge and opinion regarding the misuse and abuse of medicines in Saudi Arabia. Participants' reactions toward such behaviors were different and not consistent. Therefore, there should be a clear policy to define the role of the pharmacy staff toward the misuse and abuse of medication in Saudi Arabia.
Read ArticleREVIEW ABOUT DIABETES MELLITUS AND URINARY TRACT INFECTIONS
Diabetes mellitus (DM) is a clinical disease correlated with a deficiency of insulin secretion or action.It is one of the leading causes of morbidity and mortality worldwide. The global burden of diabetes is rising dueto increasing obesity and population aging. Urinary tract infections (UTI) are common microbial infections knownto affect the different parts of the urinary tract accounting for major antibacterial drug consumption. About 150million UTI cases were diagnosed every year. Urinary tract infections are the most important and most commonsite of infections in a diabetic patient. Diabetic patients have been found to have a 5-fold frequency of acutepyelonephritis at autopsy than non-diabetics. Most of the urinary tract infections in patients with diabetes arerelatively asymptomatic. The presence of this syndrome predisposes to much more severe infections,particularly in patients with acute ketoacidosis, poor diabetic control, diabetic complications such as neuropathy,vasculopathy, and nephropathy. The Gram-negative aerobic bacilli are the large group of bacterial pathogensthat cause UTI with few species of Gram-positive bacteria. However, some fungi, parasites, and viruses havealso been reported to invade the urinary tract. Urinary tract infection affects women more than men due toseveral factors such as proximity of the genital tract to the urethra, anatomy of the female urethra, sexualactivity, menopause, and pregnancy. Other possible risk factors of UTI include allergy, obesity, diabetes, pasthistory of UTI, contraceptive use, catheter use, and family history.
Read ArticleD-DIMER A RISK FACTOR ASSOCIATED WITH C-REACTIVE PROTEIN FOR PREDICTING THE SEVERITY OF INFECTION BY COVID-19
Background: COVID-19, caused by SARS-CoV-2, has unresolved mortality risk factors and clinical course, highlighting the need for further research. Aims: The study aimed to asses D-dimer and C-Reactive Protein (CRP) as the risk factors for severity covid-19 and who are less capable of surviving. Methods: A retrospective study conduct of COVID-19 in adult inpatients aged >20 at Al-sadder and Alamal Hospital in Iraq. Demographics, clinical trials, treatments, and viral RNA samples were analyzed. The study involved 100 patients, with 67 discharged and 33 hospitalized died. The majority of the participants 45% were aged < 40, but 55% were aged >40 years. Results: A significant and 57% were male 37(55.2%) Survivor vs. 20 (60.6%) non-survivor, p=0.024), more than 43% were female (30(44.8%) Survivor vs. 13(39.4%) non-survivor, p=0.010. Patients had underlying comorbidities (66%), survivor 37(55%), and non-survivor 29(87%). The most prominent comorbidity in non-survivors more than survivors was diabetic mellitus 85%, asthma 58%, stroke 48%, renal failure 42%, heart strake 33%, and hypertension 18%. The study found significant differences in WBC, lymphocyte count, D-dimer, Ferritin, CRP, and LDH levels in non-survivors compared to survivor patients, with a positive correlation between D- dimer and these parameters. The ROC analysis curve showed CRP with a high AUC of 80.2%, 87.9% sensitivity, and 37.3% specificity, while D-dimer and LDH had AUCs of 0.74.9 and 70%, respectively. Discussion: The study found that older age, higher d-dimer, ferritin, CRP, and LDH are associated with disease severity and higher mortality risk in adult COVID-19 patients. Conclusions: These biomarkers could aid in early detection of disease progression signs and better patient management
Read Article